CpG-ODN is also used in anti-cancer vaccines and immunotherapy, due to its ability to induce high numbers of tumor-specific cytotoxic CD8+ T cells when co-administered with HPV and melanoma tumor antigens [99,100]. This evidence concerns the gene CD8A and cancer.